Cargando…
One-Year Clinical Outcome in Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study
BACKGROUND: Prevention of stroke and systemic embolism (SE) prevention in patients with atrial fibrillation (AF) has radically changed in recent years. Data on contemporary utilization of oral anticoagulants (OACs) and cardiovascular outcome in Middle Eastern patients with AF are needed. METHODS: Th...
Autores principales: | Hammoudeh, Ayman, Khader, Yousef, Tabbalat, Ramzi, Badaineh, Yahya, Kadri, Nazih, Shawer, Haneen, Al-Mousa, Eyas, Ibdah, Rasheed, Shawer, Batool A., Alhaddad, Imad A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020983/ https://www.ncbi.nlm.nih.gov/pubmed/35462945 http://dx.doi.org/10.1155/2022/4240999 |
Ejemplares similares
-
Adherence to the 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline on the Use of Oral Anticoagulant Agents in Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study
por: Hammoudeh, Ayman J., et al.
Publicado: (2021) -
Demographics and Risk Profile of Elderly Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study
por: Alhaddad, Zayd, et al.
Publicado: (2022) -
Paroxysmal and Non-Paroxysmal Atrial Fibrillation in Middle Eastern Patients: Clinical Features and the Use of Medications. Analysis of the Jordan Atrial Fibrillation (JoFib) Study
por: Al-Makhamreh, Hanna, et al.
Publicado: (2022) -
Impact of thyroid disease in patients with atrial fibrillation: Analysis from the JoFib registry
por: Al-Makhamreh, Hanna, et al.
Publicado: (2022) -
Validation of CHA2DS2 VASc Score Predictability of Stroke and Systemic Embolization in a Middle Eastern Population with AF: The Jordan Atrial Fibrillation (JoFib) Study
por: Ibdah, Rasheed, et al.
Publicado: (2023)